Identifying subgroups of asthma patients for potential intervention using electronic medication monitors (EMM)

R. Gondalia (San Francisco, United States of America), L. Kaye (San Francisco, United States of America), D. Van Sickle (Madison, United States of America), D. Stempel (San Francisco, United States of America), M. Barrett (San Francisco, United States of America)

Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Session: Personalised treatment of obstructive diseases
Session type: E-poster session
Number: 2668
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Gondalia (San Francisco, United States of America), L. Kaye (San Francisco, United States of America), D. Van Sickle (Madison, United States of America), D. Stempel (San Francisco, United States of America), M. Barrett (San Francisco, United States of America). Identifying subgroups of asthma patients for potential intervention using electronic medication monitors (EMM). 2668

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Assessing the utility of asthma medication monitoring sensors in a group of high risk asthmatic children
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017

Clinical outcome of nutritional intervention integrated in an INTERdisciplinary COMmunity-based COPD lifestyle program (INTERCOM) in moderate COPD
Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing
Year: 2008

Evidence that children can assess their asthma medication devices
Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions
Year: 2011


Characteristics of effective self-management interventions in patients with COPD: individual patient data meta-analysis
Source: Eur Respir J 2016; 48: 55-68
Year: 2016



Effectiveness of an educational intervention in order to improve adherence in COPD and asthma ambulatory patients.
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


Facilitators and barriers of adherence to exacerbation action plans in patients with COPD and comorbidities: a qualitative study
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020


Patterns of risk of death and asthma-related adverse outcomes in adult asthma patients receiving long-acting β2-agonist (LABA) therapy: results from the UK general practice research database (GPRD)
Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care
Year: 2009


Adherence to medication advice through a remote electronic asthma and COPD service
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021


Efficacy of long-term educational program (EP) of patients with COPD
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010


Real-world patient characteristics and eligibility for biologics in severe asthma (RECOGNISE)
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting ß2-agonist use in asthma
Source: Eur Respir J, 55 (2) 1901858; 10.1183/13993003.01858-2019
Year: 2020



Engagement with an asthma app to monitor medication adherence and its association with patients’ characteristics
Source: Virtual Congress 2021 – Remote monitoring of respiratory patients
Year: 2021



Development and evaluation of an educational intervention targeted at optimising adherence with measures to prevent asthma in children with a familial allergic disposition (FOCUS-project)
Source: Eur Respir J 2002; 20: Suppl. 38, 329s
Year: 2002

QVA149 provides significant symptomatic benefit to COPD patients as measured by a new symptom e-diary: The SHINE study
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015

Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children
Source: Eur Respir J, 50 (6) 1700910; 10.1183/13993003.00910-2017
Year: 2017



Identifying inconsistencies in intervention descriptors and outcome reporting within systematic reviews of physical activity interventions in COPD
Source: International Congress 2018 – Exploring the importance of daily physical activity in chronic respiratory disease
Year: 2018




Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study)
Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015
Year: 2017



Comparing pharmacist time use for asthma and COPD patients using various types of inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


Can we change the activity behaviour of COPD patients using a telemedicine feedback intervention?
Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation
Year: 2011

Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013